Brain tryptophan metabolism in schizophrenia: a post mortem study of metabolites of the serotonin and kynurenine pathways in schizophrenic and control subjects
- PMID: 111294
- DOI: 10.1007/BF00431959
Brain tryptophan metabolism in schizophrenia: a post mortem study of metabolites of the serotonin and kynurenine pathways in schizophrenic and control subjects
Abstract
Serotonin (5HT), its chief metabolite 5-hydroxyindoleacetic acid (5 HIAA), its precursor tryptophan, and kynurenine, another metabolite of tryptophan, have been measured in post mortem human brain samples. Concentrations of these metabolites were not found to be significantly different in putamen, hippocampus or temporal cortex from 23 normal subjects compared with 15 subjects in whom a diagnosis of schizophrenia could be restrospectively confirmed. The results have been analysed with respect to cause of death, medication and post mortem changes. Post mortem increases in tryptophan and kynurenine were observed. Some interrelationships between the variables measured within and between the different areas studied are discussed. It is concluded that there is no evidence for a generalised deficit of 5HT in the brain in schizophrenia, nor for gross changes in turnover along the serotonin or kynurenine pathways of tryptophan metabolism in brain.
Similar articles
-
Brain tryptophan metabolism on the 5-hydroxytryptamine and kynurenine pathways in a strain of rats with a deficiency in platelet 5-HT.Br J Pharmacol. 1978 Jul;63(3):529-33. doi: 10.1111/j.1476-5381.1978.tb07808.x. Br J Pharmacol. 1978. PMID: 667497 Free PMC article.
-
Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.Neurochem Int. 2008 May;52(6):1297-303. doi: 10.1016/j.neuint.2008.01.013. Epub 2008 Feb 2. Neurochem Int. 2008. PMID: 18328600
-
Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.Mol Psychiatry. 2010 Sep;15(9):938-53. doi: 10.1038/mp.2009.33. Epub 2009 Apr 28. Mol Psychiatry. 2010. PMID: 19401681 Free PMC article.
-
L-kynurenine: its synthesis and possible regulatory function in brain.Neurochem Res. 1980 Mar;5(3):223-39. doi: 10.1007/BF00964611. Neurochem Res. 1980. PMID: 6154900 Review.
-
[Kynurenines in pathogenesis of endogenous psychiatric disorders].Vestn Ross Akad Med Nauk. 2013;(1):35-41. doi: 10.15690/vramn.v68i1.535. Vestn Ross Akad Med Nauk. 2013. PMID: 23805637 Review. Russian.
Cited by
-
Molecular pathology of schizophrenia: more than one disease process?Br Med J. 1980 Jan 12;280(6207):66-8. doi: 10.1136/bmj.280.6207.66. Br Med J. 1980. PMID: 6101544 Free PMC article. Review. No abstract available.
-
Proceeding of the British Pharmacological Society, Clinical Pharmacology Section, 16-18th December, 1980, University of London. Abstracts.Br J Clin Pharmacol. 1981 Apr;11(4):409P-439P. doi: 10.1111/j.1365-2125.1981.tb01148.x. Br J Clin Pharmacol. 1981. PMID: 7259939 Free PMC article. No abstract available.
-
The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.Psychopharmacology (Berl). 1993;112(1 Suppl):S5-15. doi: 10.1007/BF02245003. Psychopharmacology (Berl). 1993. PMID: 7831440 Review.
-
The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.Psychopharmacology (Berl). 1993;112(1 Suppl):S16-34. doi: 10.1007/BF02245004. Psychopharmacology (Berl). 1993. PMID: 7831438 Review.
-
Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders.Complex Psychiatry. 2021 Aug;7(1-2):19-33. doi: 10.1159/000515066. Epub 2021 Feb 8. Complex Psychiatry. 2021. PMID: 35141700 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources